Implant Preservation Devices has successfully raised $1,626,812 in investment capital from investors. The company is dedicated to addressing prosthetic joint infections (PJI), a significant complication following total joint replacement surgeries that affects almost 60,000 patients annually and places a substantial burden on healthcare systems.
Prosthetic joint infections are particularly challenging due to the formation of bacterial biofilms, which are difficult to remove and lead to recurrent infections and patient morbidity. Implant Preservation Devices offers an innovative solution through its antibacterial implant heating technology. This method utilizes induction to facilitate the removal of bacterial colonization from implants during surgery, requiring only a 1.5-minute segmental treatment intraoperatively. This targeted heating reaches areas inaccessible to traditional irrigation and antibiotics, providing a one-time operative procedure designed for high cost savings and improved patient outcomes.
This funding round represents a crucial step for Implant Preservation Devices as it advances its mission to revolutionize treatment for PJI. The secured capital will enable the company to further develop its technology and scale its operational capabilities. Implant Preservation Devices plans to strategically use these funds for continued growth initiatives, which may include expanding research and development efforts and preparing for broader market introduction of its innovative system.
The investment underscores confidence in the company's technology and its potential to significantly impact patient care and healthcare economics. Implant Preservation Devices looks forward to leveraging this capital to accelerate its development pipeline and bring its effective, cost-saving treatment to a wider patient population, ultimately reducing the incidence and severity of prosthetic joint infections.
